STING1 and neoplasm: Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity.182 Myriad immune cell types including dendritic cells, macrophages, natural killer (NK) cells, and CD4 and CD8 T cells are responsive to the antitumor effect induced by STING.